WebOct 22, 2015 · JDS Therapeutics, LLC (“JDS”), a privately-held specialty pharmaceutical company and its Nutrition 21 LLC nutritional ingredient subsidiary, announced today that it has closed a $16 million Series B institutional equity financing round led by 1315Capital, a Philadelphia-based investment firm specializing in healthcare.. More DOWNLOAD the PDF WebAug 31, 2024 · 5. The composition of claim 1, wherein the composition comprises between about 10 μg to about 1,000 μg of magnesium biotinate. 6. The composition of claim 1, wherein the composition comprises less than or equal to about 0.8% sodium by weight compared to the weight of the magnesium biotinate. 7.
Nutrition 21 Settles Patent Infringement Lawsuit
WebTo JDS Industries. Does your business print or engrave on products? We are the world's largest supplier of blanks for personalization! GIFTS AWARDS DRINKWARE SIGN … WebOct 22, 2015 · JDS Therapeutics, LLC, a privately held, specialty pharmaceutical company and its Nutrition 21, LLC, nutritional ingredient subsidiary, announced Thursday that it has … dabhol in which state
JDS Therapeutics completes $16 million financing deal
WebThe company offers scientifically-backed, natural products through a direct-to-physician sales model to physicians, healthcare-delivery networks and other healthcare professionals. Contact Information Website www.hellobonafide.com Ownership Status Privately Held (backing) Financing Status Private Equity-Backed Primary Industry Pharmaceuticals WebJul 28, 2014 · JDS Therapeutics LLC and its subsidiary Nutrition 21, LLC reported that they have entered into a confidential settlement and license agreement with SuperNutrition Life-Extension Research, Inc. WebNov 11, 2024 · HARRISON, N.Y., Nov. 11, 2024 /PRNewswire/ -- JDS Therapeutics, LLC ("JDS") announced today that it sold its specialty ingredient subsidiary, Nutrition21, LLC … dabhol breakwater project